ACDM News Item

Welcome VHypotenuse as a corporate member

Date: July 1, 2025

The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as a new corporate member.

Founded in 2021, VHypotenuse was born from a deep-rooted passion for science and technology, driven by a strong desire to make a meaningful impact on the world. Originally established as an IT and Data Management company, VHypotenuse has since expanded into the field of Clinical Research, conducting clinical trials across a range of therapeutic areas. At VHypotenuse, they are committed to delivering innovative and reliable solutions to our clients.

VHypotenuse joined the ACDM as part of its ongoing commitment to upholding the highest standards in clinical research and data integrity. The association offers a valuable platform for collaboration, learning, and contributing to best practices, supporting VHypotenuse’s mission to enhance quality, efficiency, and compliance in clinical trials while advancing patient safety and scientific rigour.

Members gain many benefits from membership, including:

Access to training courses at a discounted rate
Assign full ACDM membership to all individuals within your organisation
Place an organisation profile, description and logo on the ACDM website
Advertise jobs for your positions within your organisation
Reduced price attendance at conferences and symposia
Free attendance at Hot Topics

Find out more about becoming a corporate member here.

Explore More News

Regulatory Considerations DMEG to Review Health Canada’s Draft Guidance

Thank you to the Regulatory Considerations DMEG for sharing this update. Health Canada . . .

Recent update from the regulatory landscape in clinical data management

Thank you to the Regulatory Considerations DMEG for sharing this update. On July 15 the . . .

Regulatory Considerations DMEG Update – June 2026

Please read the following update from the Regulatory Considerations DMEG: Regulators have . . .

FDA Announces New Initiative for Real-Time Clinical Trials

The U.S. Food and Drug Administration (FDA) has announced a new initiative to support the . . .

Get to know ACDM Board Member Jennifer Duff

We caught up with one of ACDM’s new Board Members, Jennifer Duff, to learn more about her. . . .

Recent News in Regulatory Landscape

The ACDM Regulatory Considerations DMEG have kindly put together a short news piece . . .

Real-Time Clinical Data Flow: Why the FDA’s New Pilot Validates the Data Flow Modernization Agenda

Tamer Chowdhury, on behalf of ACDM Technology DMEG. On April 28, FDA Commissioner Dr. . . .

Bridging the Behaviour Gap: The Human Skills Redefining Clinical Data Management (ACDM26 Workshop Recap)

This article has been written by Gail Kniveton, who delivered the workshop “Bridging the . . .

Regulatory Considerations DMEG reviews recent MHRA regulatory updates

The ACDM Regulatory considerations DMEG Regulatory considerations reviewed several recent . . .

ACDM26 Berlin: Shaping the Future of Clinical Data Management

The ACDM Annual Conference returned to Berlin in March 2026, welcoming the global clinical . . .

Member News Update from Lab Data Solutions LLC

This news piece has been submitted by Lab Data Solutions LLC We’re Attending US Summit . . .

Welcome Veramed as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome Veramed as a . . .